• KOL
    • Carra Registry
    • Pamela F Weiss
    • Pamela F Weiss: Influence Statistics

      Pamela F Weiss

      Pamela F Weiss

      Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, United States | Children's Hospital of Philadelphia, Perelman School of ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      Pamela F Weiss:Expert Impact

      Concepts for whichPamela F Weisshas direct influence:Carra registry,Childhood arthritis,Juvenile spondyloarthritis,Juvenile arthritis,Magnetic resonance,Sacroiliac joint,Juvenile idiopathic arthritis,Psoriatic arthritis.

      Pamela F Weiss:KOL impact

      Concepts related to the work of other authors for whichfor which Pamela F Weiss has influence:Juvenile idiopathic arthritis,Ankylosing spondylitis,Temporomandibular joint,Chronic pain,Children jia,Patients psa,Rheumatic diseases.

      KOL Resume for Pamela F Weiss

      Year
      2022

      Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, United States

      2021

      University of Pennsylvania Perelman School of Medicine, Division of Rheumatology, Children's Hospital of Philadelphia and Department of Pediatrics, University of Pennsylvania, Philadelphia, USA.

      Children’s Hospital of Philadelphia, Division of Rheumatology, Philadelphia, PA USA

      Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

      2020

      Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, USA

      2019

      Department of Pediatrics, Division of Rheumatology, Children's Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA, 19104, United States; Perelman School of Medicine at University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA, 19104, United States; Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Roberts Center for Pediatric Research, Philadelphia, PA,19146, United States.

      Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 3501 Civic Center Blvd, Colket Translational Research Bldg, #10100-7, 19104, Philadelphia, PA, USA

      Division of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

      2018

      Department of Rheumatology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

      Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

      Division of Rheumatology

      2017

      Division of Pediatric Rheumatology, The Children’s Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Wood Building, Fourth Floor, 19104, Philadelphia, PA, USA

      Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia

      Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania.

      2016

      Division of Rheumatology, Department of Paediatrics, Children's Hospital of Philadelphia; and Department of Paediatrics, Center for Paediatric Clinical Effectiveness, Children's Hospital of Philadelphia, PA, USA.

      Children's Hospital of Philadelphia Philadelphia Pennsylvania

      2015

      From the Department of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia; Center for Epidemiology and Biostatistics, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.A.J. Taxter, MD, Fellow, Department of Pediatric Rheumatology, The Children's Hospital of Philadelphia; E.P. Wileyto, PhD, Associate Professor, Center for Epidemiology and Biostatistics, The University of Pennsylvania; E.M. Behrens, MD, Associate Professor, Department of Pediatric Rheumatology, The Children's Hospital of Philadelphia; P.F. Weiss, MD, MSCE, Associate Professor, Department of Pediatric Rheumatology, and Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia.

      Children's Hospital of Philadelphia, Philadelphia, PA.

      Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA

      2014

      Division of Rheumatology, Children’s Hospital of Philadelphia, 3405 Civic Center Blvd, Philadelphia, PA 19104 USA

      University of Pennsylvania Perelman School of Medicine and Children's Hospital of Philadelphia Philadelphia

      Sample of concepts for which Pamela F Weiss is among the top experts in the world.
      Concept World rank
      sis structural #1
      interpretation joints #1
      israeli jspa #1
      ses patientparent concordance #1
      local radiology reports #1
      racial disparities target #1
      distribution spondylarthritis #1
      jspa disease #1
      glucocorticoid exposure children #1
      sis tnfi #1
      conditions multisystem #1
      sacroiliac joint children #1
      disease outcomes time #1
      challenging complex conditions #1
      biologic development #1
      biologic plan #1
      psa ibda #1
      jia cno #1
      enthesitis prevalent #1
      psoriasis tnfi #1
      average tnfi #1
      israeli jspa patients #1
      cjadas10 time #1
      tnfi spa patients #1
      predominately enthesitis enthesitis #1
      race disease outcomes #1
      treatment regimens adults #1
      disease phenotype evaluation #1
      normal volume fluid #1
      tuq scores #1
      sensitivity local reports #1
      domain short form #1
      imaging phenotype children #1
      examination key components #1
      tnfi unexposed #1
      hip joint 21 #1
      incident cjadas10 #1
      children tnfi exposure #1
      iqr subscales #1
      hospitalized new #1
      biologics treatment variation #1
      radiographs axial disease #1
      ibd juvenile #1
      glucocorticoids biologics #1
      treatment variation hospitals #1
      microbiome γδt cells #1
      average tnfi exposure #1
      0007conclusionisraeli children #1

      Prominent publications by Pamela F Weiss

      KOL-Index: 13564

      BACKGROUND: Depression and anxiety adversely affects outcomes in systemic lupus erythematosus (SLE) and healthcare utilization is high for pediatric SLE. We aimed to characterize the prevalence of depression and anxiety in pediatric SLE, and their association with healthcare utilization.

      METHODS: We conducted a cross-sectional analysis of pediatric SLE and mixed connective tissue disease (MCTD) subjects and healthy controls aged 8 years and above. We used the Patient Health Questionnaire ...

      Known for Sle Mctd | Pediatric Lupus | Depression Anxiety | Connective Tissue | Suicidal Ideation
      KOL-Index: 12674

      OBJECTIVE: To determine the prevalence of temporomandibular joint (TMJ) disease in a cohort of children with new-onset juvenile idiopathic arthritis (JIA), and to compare magnetic resonance imaging (MRI) with ultrasound (US) for the detection of acute and chronic changes of TMJ arthritis.

      METHODS: Between January 2005 and April 2007, children with newly diagnosed JIA were prospectively evaluated for TMJ arthritis. Prior to imaging, jaw pain and disability were assessed with ...

      Known for Tmj Arthritis | Magnetic Resonance | Children Mri | Disease Onset | Temporomandibular Joint
      KOL-Index: 11660

      OBJECTIVE: There is wide variation in therapeutic approaches to systemic juvenile idiopathic arthritis (JIA) among North American rheumatologists. Understanding the comparative effectiveness of the diverse therapeutic options available for treatment of systemic JIA can result in better health outcomes. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) developed consensus treatment plans and standardized assessment schedules for use in clinical practice to facilitate such ...

      Known for Treatment Plans | Systemic Juvenile | Comparative Effectiveness | Idiopathic Arthritis | Infant Interleukin
      KOL-Index: 11457

      OBJECTIVE: To provide evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA).

      METHODS: A core group led the development of the recommendations, starting with the treatment questions. A literature review group conducted systematic literature reviews of studies that addressed 57 specific treatment questions, based on searches conducted in OVID Medline (1946-2014), PubMed (1966-2014), and the Cochrane ...

      Known for Ankylosing Spondylitis | Nonradiographic Axial | Tnfi Patients | United States | Recommendations Treatment
      KOL-Index: 10651

      OBJECTIVE: To evaluate the prevalence of sacroiliitis at diagnosis of juvenile spondyloarthritis (SpA) and the accuracy of physical examination and back pain to detect sacroiliitis, using imaging as the reference standard.

      METHODS: We performed a prospective cross-sectional study of 40 children with newly diagnosed juvenile SpA and 14 healthy controls. Subjects were assessed using physical examination, anteroposterior pelvic radiograph, and pelvic magnetic resonance imaging (MRI). ...

      Known for Juvenile Spondyloarthritis | Clinical Examination | Magnetic Resonance | Sacroiliitis Mri | Reference Standard
      KOL-Index: 10059

      OBJECTIVE: To assess the relative effect of clinical factors and medications on pain intensity, physical function, and health status in juvenile idiopathic arthritis (JIA).

      METHODS: We conducted a retrospective cross-sectional study of data from children with JIA enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. We tested whether clinical characteristics of JIA were associated with pain intensity, physical function, and health status using ...

      Known for Physical Function | Pain Intensity | Jia Categories | Idiopathic Arthritis | Carra Registry
      KOL-Index: 9940

      OBJECTIVE: To estimate the incidence rate (IR) of psoriasis in children with inflammatory bowel disease (IBD), juvenile idiopathic arthritis (JIA), and chronic noninfectious osteomyelitis (CNO) with tumor necrosis factor inhibitor (TNFi) exposure as compared to children without TNFi exposure and to the general pediatric population.

      METHODS: This was a single-center retrospective cohort study of children with IBD, JIA, or CNO from 2008 to 2018. TNFi exposure was defined as a prescription ...

      Known for Psoriasis Children | Tnfi Exposure | Jia Cno | Necrosis Factor | Inflammatory Bowel Disease
      KOL-Index: 9738

      OBJECTIVE: There is no standardized approach to the initial treatment of polyarticular juvenile idiopathic arthritis (JIA) among pediatric rheumatologists. Understanding the comparative effectiveness of the diverse therapeutic options available will result in better health outcomes for polyarticular JIA. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) developed consensus treatment plans (CTPs) for use in clinical practice to facilitate such studies.

      METHODS: A ...

      Known for Consensus Treatment | Polyarticular Juvenile | Idiopathic Arthritis | Comparative Effectiveness | Biologic Plan
      KOL-Index: 9643

      OBJECTIVE: To investigate differences in risk factors for depression and anxiety, such as central nervous system involvement in systemic lupus erythematosus (SLE)/mixed connective tissue disease (MCTD), by comparing youth with SLE/MCTD to peers with type 1 diabetes mellitus (T1D).

      STUDY DESIGN: We conducted a cross-sectional study of 50 outpatient pairs, ages 8 years and above, matching subjects with SLE/MCTD and T1D by sex and age group. We screened for depression, suicidal ideation, ...

      Known for Depression Anxiety | Suicidal Ideation | Connective Tissue | Mental Health | Systemic Lupus Erythematosus
      KOL-Index: 9276

      OBJECTIVE: In adults, gadolinium contrast enhancement does not add incremental value to fluid-sensitive sequences for evaluation of bone marrow edema. This study was undertaken to determine if magnetic resonance imaging (MRI) contrast is necessary to assess lesions consistent with inflammatory sacroiliitis in children.

      METHODS: Patients with clinically suspected or diagnosed juvenile spondyloarthritis (SpA) underwent pelvic MRI consisting of multiplanar fluid-sensitive and postgadolinium ...

      Known for Magnetic Resonance | Inflammatory Sacroiliitis | Fluidsensitive Sequences | Postcontrast Imaging | Bone Marrow Edema
      KOL-Index: 9251

      OBJECTIVE: To characterize disease-modifying antirheumatic drug (DMARD) use for children with juvenile idiopathic arthritis (JIA) in the United States and to determine patient factors associated with medication use.

      METHODS: We analyzed cross-sectional baseline enrollment data from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry from May 2010 through May 2011 for children with JIA. Current and prior medication use was included. We used parsimonious backward ...

      Known for Carra Registry | Children Jia | Monoclonal Antibodies | Idiopathic Arthritis | Modifying Antirheumatic
      KOL-Index: 8719

      ObjectivesTo assess the feasibility of studying the comparative effectiveness of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) consensus treatment plans (CTPs) for systemic Juvenile Idiopathic Arthritis (JIA) using an observational registry.MethodsUntreated systemic JIA patients enrolled in the CARRA Registry were begun on one of 4 CTPs chosen by the treating physician and patient/family (glucocorticoid [GC] alone; methotrexate [MTX] ± GC; IL1 inhibitor [IL1i] ± GC; ...

      Known for Systemic Juvenile | Consensus Treatment | Monoclonal Antibodies | Idiopathic Arthritis | Carra Registry
      KOL-Index: 8388

      OBJECTIVE: To provide evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA).

      METHODS: A core group led the development of the recommendations, starting with the treatment questions. A literature review group conducted systematic literature reviews of studies that addressed 57 specific treatment questions, based on searches conducted in OVID Medline (1946-2014), PubMed (1966-2014), and the Cochrane ...

      Known for Ankylosing Spondylitis | Nonradiographic Axial | Tnfi Patients | Recommendations Treatment | Spondyloarthritis Spa
      KOL-Index: 8290

      OBJECTIVE: To evaluate the precision and construct validity of pediatric Patient-Reported Outcomes Measurement Information System (PROMIS) instruments in a population of juvenile idiopathic arthritis (JIA) patients and parent proxies.

      METHODS: A convenience sample of JIA patients and parents of JIA patients completed PROMIS instruments for 8 domains: anger, anxiety, depressive symptoms, fatigue, mobility, pain interference, peer relationships, and upper-extremity function. Short form and ...

      Known for Juvenile Arthritis | Reported Outcomes | Pain Interference | Depressive Symptoms | Peer Relationships
      KOL-Index: 7541

      OBJECTIVE: There is a critical need for measures to evaluate structural progression in the pediatric sacroiliac joint (SIJ). We aimed to evaluate the construct validity and reliability of the Spondyloarthritis Research Consortium of Canada SIJ Structural Score (SSS) in children with suspected or confirmed juvenile spondyloarthritis.

      METHODS: The SSS assesses structural lesions of the SIJ on magnetic resonance imaging (MRI) through the cartilaginous part of the joint. We conducted 3 ...

      Known for Sacroiliac Joint | Fat Metaplasia | Backfill Sclerosis | Structural Score | Magnetic Resonance Imaging

      Key People For Carra Registry

      Top KOLs in the world
      #1
      Earl Dean Silverman
      lupus erythematosus kawasaki disease juvenile rheumatoid arthritis
      #2
      Brian Michael Feldman
      juvenile dermatomyositis carra registry rheumatic diseases
      #3
      Alberto Martini
      juvenile idiopathic arthritis inactive disease macrophage activation syndrome
      #4
      Rayfel Schneider
      carra registry juvenile idiopathic arthritis macrophage activation syndrome
      #5
      Angelo Ravelli
      juvenile idiopathic arthritis macrophage activation syndrome inactive disease
      #6
      Timothy Beukelman
      juvenile idiopathic arthritis carra registry united states

      Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, United States | Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States | Center

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.